1. Home
  2. ARVN vs TALK Comparison

ARVN vs TALK Comparison

Compare ARVN & TALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$8.95

Market Cap

658.2M

Sector

Health Care

ML Signal

HOLD

Logo Talkspace Inc.

TALK

Talkspace Inc.

HOLD

Current Price

$5.19

Market Cap

788.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARVN
TALK
Founded
2015
2012
Country
United States
United States
Employees
N/A
521
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
658.2M
788.5M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ARVN
TALK
Price
$8.95
$5.19
Analyst Decision
Buy
Buy
Analyst Count
19
6
Target Price
$15.05
$6.42
AVG Volume (30 Days)
858.9K
1.3M
Earning Date
05-04-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
58.84
N/A
EPS
N/A
N/A
Revenue
$262,600,000.00
N/A
Revenue This Year
N/A
$26.02
Revenue Next Year
N/A
$21.24
P/E Ratio
N/A
$155.55
Revenue Growth
N/A
N/A
52 Week Low
$6.06
$2.22
52 Week High
$14.22
$5.20

Technical Indicators

Market Signals
Indicator
ARVN
TALK
Relative Strength Index (RSI) 37.05 55.78
Support Level $8.72 $4.59
Resistance Level $10.18 $5.20
Average True Range (ATR) 0.47 0.01
MACD 0.00 -0.00
Stochastic Oscillator 28.82 50.50

Price Performance

Historical Comparison
ARVN
TALK

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

About TALK Talkspace Inc.

Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.

Share on Social Networks: